April 2009 Preview of the 2009 ASCO Annual Meeting: Personalizing Cancer Care Look inside: Select One

Spotlight Discover Orlando: An Insiders Guide This visitor's guide for Annual Meeting attendees features recommendations from area residents Gregory Pennock, MD, and Roy Ambinder, MD. FDA Honors ASCO for Critical Path Initiative FDA Commissioner Andrew von Eschenbach, MD, presented a special award to ASCO CEO Allen S. Lichter, MD, in December. Membership Series ASCO News & Forum continues its new series about the benefits of ASCO membership with an interview with community oncologists, William Charles Penley, MD, and Mary Wilkinson, MD. Current Controversies in Oncology The Controversey: HER2 Testing for Breast Cancer Edith A. Perez, MD, and Giuseppe Viale, MD, offer two perspectives on this debate, with an introduction by Antonio C. Wolff, MD, FACO. ASCO News & Forum wants to hear from you.

Online Exclusives

Spotlight on State Affiliates: Florida Society of Clinical Oncology: FLASCO has made establishing a statewide clinical trials network one of its top priorities.

New Guideline Addresses Chemoprevention for Prostate Cancer: JCO published the ASCO/AUA Clinical Practice Guidelines with recommendations on the use of 5-Alpha Reductase Inhibitors (5-ARIs) for chemoprevention of prostate cancer

Physical Activity and Cancer Care: Richard Troiano, PhD, describes the development of the first-ever federal guidelines on physical activity for Americans, and how they affect cancer care.

ASCO Issues First Provisional Clinical Opinion at 2009 GI Symposium: A study presented at the 2009 GI Cancers Symposium discussed the possibility of more than half a billion dollars in savings for the United States health care system, which prompted ASCO to issue its first Provisional Clinical Opinion.

Spotlight on State Affiliates: Maryland-D.C. Society of Clinical Oncology: Pat Troy discusses MDCSCO's successful community outreach program.